SOLICITATION NOTICE
Q -- Ocular Toxoplasma Study
- Notice Date
- 8/13/2007
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- 2007-Q-09838
- Response Due
- 8/22/2007
- Archive Date
- 9/6/2007
- Description
- The Centers for Disease Control and Prevention intends to issue a sole source firm fixed priced purchase order to Toxoplasma Serology Laboratory, Research Institute, Palo Alto Medical Foundation, Palo Alto, California 94301, the only known entity to perform anti-toxoplasma IgM and IgG antibody testing on samples from at least 50 persons with ocular toxoplasmosis, and for those sera with positive anti-toxoplasmosis IgM and IgG antibodies perform the full toxoplasma testing panel. To initiate the study, the vendor shall obtain approval for a human-subjects review board protocol from 4 or more ocular disease center institutional review boards (IRBs), the Stanford University IRB, the PAMF IRB, and the CDC IRB (to request deferral to the PAMF IRB). Patients will be identified with T. gondii-associated ocular disease at the participating centers. The PAMF with perform anti-Toxoplasma IgM and IgG antibody testing, and for those sera with positive anti-Toxoplasma IgM and IgG antibodies perform the full Toxoplasma testing panel, which includes the dye test (if not done previously), avidity test, IgE ELISA, IgA ELISA, and differential agglutination (AC/HS). For serum samples that are anti-Toxoplasma IgG and IgM positive the PAMF will perform (or subcontract to perform) a series of peptide-specific serologic tests to determine if the infection is due to genetic types 1 and 3, or type 2 T. gondii. Also for serum samples that are anti-Toxoplasma IgG and IgM positive, the PAMF will perform polymerase chain reaction testing on whole blood to determine if patients are parasitemic. These data will then be entered into computer software, which shall be provided to CDC, and periodic summary reports will be made to CDC. Only one responsible source and no other services will satisfy agency requirements. The proposed contract action is for commercial items which the Government intends to solicit and negotiate with only one source under authority of FAR subpart 27.4. Interested persons may identify their interest and capability to respond to the requirement. THIS IS A COMBINED SYNOPSIS/SOLICITATION FOR COMMERCIAL ITEMS PREPARED IN ACCORDANCE WITH THE FORMAT IN SUBPART 12.6, AS SUPPLEMENTED WITH ADDITIONAL INFORMATION INCLUDED IN THIS NOTICE. THIS ANNOUNCEMENT CONSTITUTES THE ONLY ONE THAT WILL NOT BE ISSUED. The following provision(s) apply to this acquisition: 52.212-1 Instructions to Offerors ? Commercial Items (MAR 2000) applies to this acquisition; 52.223-13 Certification of Toxic Chemical Release Reporting; 52.223-14 Toxic Chemical Release Reporting; 52.232-1 Payments; 52.233-3 Protest After Award; 52.201-1 Definitions; 52.203-5 Covenant Against Contingent Fees; 52.203-7 Anti-Kickback Procedures; 52.204-7 Central Contractor Registration; Contractor must be CCR Registered prior to submitting bid; The clause 52.212-4, Contract Terms & Conditions - Commercial Items (MAY 1999) applies to this acquisition. The following FAR Clauses are hereby added to this clause: 52.247-35 F.O.B. Destination; The clause at 52.212-5 - Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items applies to this acquisition. The following clauses listed in paragraph (b) of 52.212-5 apply to this acquisition: (1), (5), (7), (14), (15), (16), (17), (18), (22), (24), (29) and (30). 52.213-3 must be attached to bid. NAICS CODE: 424210, SIC: 5122 SIZE: 100, OFFERORS SHALL INCLUDE A COMPLETED COPY OF THE PROVISION AT 52.212-3, OFFERORS REPRESENTATIONS AND CERTIFICATIONS - COMMERCIAL ITEMS, WITH YOUR QUOTE. The best way to complete this certification is to download the FAR Clauses (Volume II) at http://www.arnet.gov/far, print out the clause 52.212-3, Offeror Representation and Certification, and fill in the appropriate blanks. Documentation authority for synopsis urgent response on file. Offers will be due 03/27/2006 by 5:00 P.M. EST at Centers for Disease Control and Prevention; Procurements and Grants Office; Attn: Gary Morgan; 2920 Brandywine Road, M/S K70, Room 3710.01, Atlanta, GA 30341. Offers will not be accepted facsimile. All quotes must be clearly marked on the subject line of the e-mail (Solicitation #2007-Q-09838) or on the outside of the envelope with the following: Solicitation# 2007-Q-09838, Attn: Gary Morgan. All responsible sources that can meet the above requirements may submit a quote, which may be considered by the Agency. For Contractual question contact Gary Morgan (770) 488-2639. ****
- Place of Performance
- Address: Atlanta, Georgia
- Zip Code: 30341
- Country: UNITED STATES
- Zip Code: 30341
- Record
- SN01370498-W 20070815/070813220348 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |